We’re called Q’Apel for the Qu’Appelle River, a waterway that winds through Saskatchewan, Canada. Why? Because this pristine river charts a winding path, full of twists, turns, and straightaways alike. That’s what we do, too. Our cutting-edge products—neurological catheters, specifically—are designed to navigate the twists and turns of the brain’s neurovasculature, empowering therapeutic thrombectomy and cerebral aneurysm devices to deliver life-changing outcomes.Who We Are
Jeff Krolik is a medical device entrepreneur with over 25 years of experience developing innovative devices. Before joining Q’Apel he served as Vice President of Engineering at Hotspur Technologies, where he led the development of the GPSCath PTCA catheter which was sold to Teleflex medical in July 2012. Prior to that, Jeff served as Vice President of Research and Development at SquareOne, Inc. where he led the development of the BOSS Ostial Stent System from inception through its first human clinical use. Jeff also served as the lead engineer on the FilterWire EX Embolic Protection System for Embolic Protection Inc., later acquired by Boston Scientific. Jeff is an inventor on 54 issued US patents and holds a B.S. in Materials Science and Engineering from San Jose State University.
“Q’Apel was founded on the concept that changes in clinical practice create opportunities for product innovation. We are lucky that our users are constantly finding better ways to treat patients, and we strive to meet the challenge with rapid execution and high-quality products that are tuned to today’s interventional technique.”
By working side by side with neurological specialists and caregivers, we craft solutions that get straight to the heart of what’s needed. Reach out to learn more.